Table 1: Demographic and clinical comparisons between the VR and control groups. Data are median (IQR) or N (%).
|
|
Control |
VR |
p |
|
Age (years) |
39 (32-45) |
39 (28-47) |
0.660 |
|
ASA |
1 (1-2) |
1(1-2) |
0.730 |
|
PACU times (min) |
20 (15-25) |
15 (13-20) |
0.011 |
|
Female Gender |
26 (68%) |
33 (52%) |
0.114 |